Flora Peyvandi/X
Sep 13, 2025, 01:37
Flora Peyvandi on Iron Deficiency in Mild to Moderate Bleeding Disorders
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
“Prevalence of iron deficiency in patients with mild to moderate bleeding disorders and bleeding disorder of unknown cause: this data highlight the importance of assessing iron status in patients with MBDs, especially in young female individuals …..”
Title: Prevalence of iron deficiency in patients with mild to moderate bleeding disorders and bleeding disorder of unknown cause
Authors: Tim Dreier, Dino Mehic, Justin Oosterlee, Jasmin Rast, Alexandra Kaider, Helmuth Haslacher, Cihan Ay, Ingrid Pabinger, Johanna Gebhart
Read the full article here.
Find more on Hemostasis Today.
-
Sep 12, 2025, 06:39Chokri Ben Lamine: Approach to Intra-Operative Bleeding in G6P Deficiency – Key Causes and Management
-
Sep 11, 2025, 15:42The True Price of Gene Therapy: Breaking Down Beqvez’s $3.5M Cost and What Really Drives It
-
Sep 11, 2025, 14:49Samantha Nelson Shares "The Beat" - World Thrombosis Day Just Added Newsletter to LinkedIn
-
Sep 11, 2025, 13:01Do Not Miss ISTH Fast Five! Pediatric and Neonatal Thrombosis & Hemostasis and Many More Webinars
-
Sep 11, 2025, 08:33Alfonso J. Tafur Shares VascuLearn’s Free Virtual Support Groups This Fall for Patients and Providers
-
Sep 13, 2025, 01:37Flora Peyvandi on Iron Deficiency in Mild to Moderate Bleeding Disorders
-
Sep 12, 2025, 07:28Lauren Murphy: Platelets as DNA “Sponges”
-
Sep 12, 2025, 03:38Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
-
Sep 11, 2025, 15:03Rapid ADAMTS13 Assays: A Key Milestone in the 100 Years of Innvoation in TTP Diagnosis - Silvio Castagni
-
Sep 11, 2025, 14:25Thrombin Generation Assays to Assess COC-Associated Procoagulant Alterations
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 12, 2025, 07:20Women for Their Health: Paige Bingham on Boston Scientific's Initiative ''Close the Gap'' Act During AFib Awareness Month
-
Sep 11, 2025, 15:27Postpartum Haemorrhage: In Kenya, More than 120 Mothers Die for Every 100,000 Live Births
-
Sep 11, 2025, 15:11Join the Global Effort: World Thrombosis Day Campaign for Healthcare and Community Organizations
-
Sep 11, 2025, 14:26José Antonio García Erce: Self-Sufficiency in Blood Products - Utopia or Reality?
-
Sep 11, 2025, 08:08Al-Ola A Abdallah on MGUS-Related Bleeding Disorders
Sep 13, 2025, 01:37
Sep 12, 2025, 16:11
Sep 12, 2025, 07:28
Sep 12, 2025, 05:27